Heeyeon Cho

Heeyeon Cho

Auto-generated profile, based on publicly available information

Heeyeon Cho

Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
EPEujin Park
Eujin Park
CLChung Lee
Chung Lee
NKNayoung Kim
Nayoung Kim
YAYo Han Ahn
Yo Han Ahn
YPYoung Seo Park
Young Seo Park
HCHae Il Cheong
Hae Il Cheong
Steroid-resistant nephrotic syndrome (SRNS) is one of the major causes of end-stage renal disease (ESRD) in childhood and is mostly associated with focal segmental glomerulosclerosis (FSGS). More than 50 monogenic causes of SRNS or FSGS have been identified. Recently, the mutation detection rate in pediatric patients with SRNS has been reported to be approximately 30%. In this study, genotype-phenotype correlations in a cohort of 291 Korean pediatric patients with SRNS/FSGS were analyzed. The overall mutation detection rate was 43.6% (127 of 291 patients). WT1 was the most common causative gene (23.6%), followed by COQ6 (8.7%), NPHS1 (8.7%), NUP107 (7.1%), and COQ8B (6.3%). Mutations in COQ6, NUP107, and COQ8B were more frequently detected, and mutations in NPHS2 were less commonly detected in this cohort than in study cohorts from Western countries. The mutation detection rate was higher in patients with congenital onset, those who presented with proteinuria or chronic kidney disease/ESRD, and those who did not receive steroid treatment. Genetic diagnosis in patients with SRNS provides not only definitive diagnosis but also valuable information for decisions on treatment policy and prediction of prognosis. Therefore, further genotype-phenotype correlation studies are required.

14 March 2016 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
SLSang Taek Lee
Sang Taek Lee
HCHeeyeon Cho
Heeyeon Cho

1 January 2015 in Korean Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
HCHeeyeon Cho
Heeyeon Cho
Cho H. Korean J Pediatr. 2015 Jul;58(7):239-244. http://dx.doi.org/10.3345/kjp.2015.58.7.239

1 January 2016 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
HCHae Il Cheong
Hae Il Cheong
Sang-Kyung JoSang-Kyung Jo
Sang-Kyung Jo
SYSung-Soo Yoon
Sung-Soo Yoon
HCHeeyeon Cho
Heeyeon Cho
JKJIN SEOK KIM
JIN SEOK KIM
DODoyeun Oh
Doyeun Oh
Cheong HI, et al. J Korean Med Sci. 2016 Oct;31(10):1516-1528. https://doi.org/10.3346/jkms.2016.31.10.1516

1 January 2013 in Korean Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
HHHye Sun Hyun
Hye Sun Hyun
KPKyung Hoon Paik
Kyung Hoon Paik
HCHee Yeon Cho
Hee Yeon Cho
Indoxyl sulfate and p-cresyl sulfate are important protein-bound uremic retention solutes whose levels can be partially reduced by renal replacement therapy. These solutes originate from intestinal bacterial protein fermentation and are associated with cardiovascular outcomes and chronic kidney disease progression. The aims of this study were to investigate the levels of indoxyl sulfate and p-cresyl sulfate as well as the effect of probiotics on reducing the levels of uremic toxins in pediatric patients on dialysis. We enrolled 20 pediatric patients undergoing chronic dialysis; 16 patients completed the study. The patients underwent a 12-week regimen of VSL#3, a high-concentration probiotic preparation, and the serum levels of indoxyl sulfate and p-cresyl sulfate were measured before treatment and at 4, 8, and 12 weeks after the regimen by using fluorescence liquid chromatography. To assess the normal range of indoxyl sulfate and p-cresyl sulfate we enrolled the 16 children with normal glomerular filtration rate who had visited an outpatient clinic for asymptomatic microscopic hematuria that had been detected by a school screening in August 2011. The baseline serum levels of indoxyl sulfate and p-cresyl sulfate in the patients on chronic dialysis were significantly higher than those in the children with microscopic hematuria. The baseline serum levels of p-cresyl sulfate in the peritoneal dialysis group were significantly higher than those in the hemodialysis group. There were no significant changes in the levels of these uremic solutes after 12-week VSL#3 treatment in the patients on chronic dialysis. The levels of the uremic toxins p-cresyl sulfate and indoxyl sulfate are highly elevated in pediatric patients on dialysis, but there was no significant effect by probiotics on the reduction of uremic toxins in pediatric dialysis patients. Therefore, studies for other medical intervention to reduce uremic toxins are also necessary in pediatric patients on dialysis.

29 January 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KLKeum Hwa Lee
Keum Hwa Lee
EPEujin Park
Eujin Park
HCHyun Jin Choi
Hyun Jin Choi
HKHee Gyung Kang
Hee Gyung Kang
IHIl-Soo Ha
Il-Soo Ha
Jae Il ShinJae Il Shin
Jae Il Shin
Children with chronic kidney disease (CKD) are at high risk of anemia, an important risk factor for cardiovascular disease and poor quality of life. The present study used baseline data from the Korean cohort study for Outcome in patients With Pediatric Chronic Kidney Disease (KNOW-PedCKD). A Total of 437 patients was included in the analyses excluding missing data. The characteristics of patients with and without anemia and those of patients with and without iron deficiency were compared. Logistic regression analysis and Pearson correlation were conducted to evaluate associated risk factors and correlations in children with CKD. Anemia in children with CKD was associated with older age, low body weight and body mass index (BMI) z-score, birth age, preceding glomerulonephritis, decreased estimated glomerular filtration rate (eGFR), low levels of serum albumin and calcium, high levels of serum intact parathyroid hormone (iPTH), and serum phosphorus. Anemia was correlated positively with changes in the BMI z-score, body weight, and serum albumin and cholesterol levels, but correlated negatively with serum calcium, iPTH, ferritin levels, and transferrin saturation. Iron deficiency in children with CKD was associated with young age, low hemoglobin and serum ferritin levels, high BMI z-scores, and low levels of serum iPTH. This is the first nationwide cohort study of anemia in Korean children with CKD and the first prospective pediatric CKD cohort study in Asia. The study results demonstrated that anemia and iron deficiency are affected by various factors, including age, BMI, and levels of serum iPTH. To improve the retrospective outcome of affected children, it is important to understand the effect of each of these factors and to attempt an early intervention to prevent anemia and iron deficiency by regular measurement of these parameters in children at risk.